APALUTAMIDE

Auto-translated from Polish

Original title: APALUTAMIDUM

Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii

Published: Oct 5, 2026

Updated: Oct 6, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Polish

This tender, originating from Poland and sourced via TED, concerns the procurement of "APALUTAMIDUM" in the form specified as "tabl. powl. 20 mg" (film-coated tablets, 20 mg). Apalutamide is a medication used for the treatment of prostate cancer. This procurement is likely for pharmaceutical supplies intended for a healthcare institution, hospital, or public health program in Poland. Typical requirements for such a tender would include adherence to strict pharmaceutical quality standards (e.g., GMP - Good Manufacturing Practice), regulatory compliance with Polish and EU pharmaceutical laws, and specific packaging and labeling requirements. Bidders are expected to provide detailed product information, including manufacturer details, batch specifications, expiry dates, and proof of marketing authorization. The tender aims to secure a reliable supply of this specific medication at the required dosage and formulation, ensuring patient access to essential cancer treatment within the Polish healthcare system.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 5, 2026. Last refreshed today. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii

Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii has issued 114 procurement notices on BidsFactory, including 17 currently open and 27 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU) and Poland e-Zamówienia. Most recent publication: October 6, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.